
At a gathering of the world’s business and political titans last week, Google CEO Sundar Pichai became the latest tech leader to sharpen his focus on health care.
“Look at the potential here,” Pichai told a panel at the World Economic Forum’s annual meeting in Davos, Switzerland. “Cancer [is] often missed and the difference in outcome is profound,” he said, adding, “We know we can use artificial intelligence to make it better.”
Artificial intelligence is only part of Google’s and its parent-company Alphabet’s health footprint. Over the past half decade, Google, Alphabet, and another of its subsidiaries, Verily (formerly Google Life Sciences), have made sizable inroads across a wide range of potential health applications — from creating devices for people with hand tremor to studying algorithms designed to help clinicians better spot breast cancer.